- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-pentamer
- Ligands
- 5 x JC8: 6-[5-[(1~{R},2~{R},4~{S})-7-azabicyclo[2.2.1]heptan-2-yl]-2-fluoranyl-pyridin-3-yl]pyridine-3-carboxamide(Non-covalent)
- 8 x PO4: PHOSPHATE ION(Non-functional Binders)
PO4.2: 7 residues within 4Å:- Chain A: K.42, S.167, E.170, E.210
- Chain B: D.94, R.96
- Ligands: JC8.1
5 PLIP interactions:4 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:S.167, A:E.170, A:E.210
- Salt bridges: A:K.42, B:R.96
PO4.3: 10 residues within 4Å:- Chain A: A.109, Y.110, S.111, S.112, M.143, W.164
- Chain B: Q.55, V.70, L.119, A.137
5 PLIP interactions:4 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:Y.110, A:Y.110, A:S.112, A:S.112, B:Q.55
PO4.10: 7 residues within 4Å:- Chain B: K.42, S.167, E.170, E.210
- Chain C: D.94, R.96
- Ligands: JC8.9
6 PLIP interactions:4 interactions with chain B, 2 interactions with chain C- Hydrogen bonds: B:S.167, B:E.210, B:E.210, C:D.94
- Salt bridges: B:K.42, C:R.96
PO4.15: 7 residues within 4Å:- Chain C: K.42, S.167, E.170, E.210
- Chain D: D.94, R.96
- Ligands: JC8.14
5 PLIP interactions:2 interactions with chain D, 3 interactions with chain C- Hydrogen bonds: D:D.94, C:S.167, C:E.170
- Salt bridges: D:R.96, C:K.42
PO4.23: 7 residues within 4Å:- Chain D: K.42, S.167, E.170, E.210
- Chain E: D.94, R.96
- Ligands: JC8.22
7 PLIP interactions:2 interactions with chain E, 5 interactions with chain D- Hydrogen bonds: E:D.94, D:S.167, D:S.167, D:E.170, D:E.170
- Salt bridges: E:R.96, D:K.42
PO4.24: 10 residues within 4Å:- Chain D: A.109, Y.110, S.111, S.112, W.164
- Chain E: Q.55, V.70, L.119, A.137
- Ligands: EDO.28
5 PLIP interactions:3 interactions with chain E, 2 interactions with chain D- Hydrogen bonds: E:Q.55, E:Q.55, E:Q.55, D:A.109, D:S.112
PO4.31: 7 residues within 4Å:- Chain A: D.94, R.96
- Chain E: K.42, S.167, E.170, E.210
- Ligands: JC8.30
4 PLIP interactions:3 interactions with chain E, 1 interactions with chain A- Hydrogen bonds: E:S.167, E:E.210
- Salt bridges: E:K.42, A:R.96
PO4.32: 8 residues within 4Å:- Chain A: Q.55, L.119, A.137
- Chain E: A.109, Y.110, S.111, S.112, W.164
3 PLIP interactions:2 interactions with chain E, 1 interactions with chain A- Hydrogen bonds: E:Y.110, E:S.112, A:Q.55
- 18 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.4: 7 residues within 4Å:- Chain A: P.38, G.39, P.40, Y.166
- Chain B: L.23, F.95, R.96
Ligand excluded by PLIPEDO.5: 5 residues within 4Å:- Chain A: L.46, T.47, R.76, W.77, K.78
Ligand excluded by PLIPEDO.6: 3 residues within 4Å:- Chain A: T.41, K.42
- Chain B: D.94
Ligand excluded by PLIPEDO.8: 7 residues within 4Å:- Chain A: T.108, A.109, S.112, R.114, P.115, V.116
- Chain B: L.119
Ligand excluded by PLIPEDO.11: 8 residues within 4Å:- Chain B: P.38, G.39, P.40, Y.166
- Chain C: L.23, D.94, F.95, R.96
Ligand excluded by PLIPEDO.13: 4 residues within 4Å:- Chain B: P.115, V.116
- Chain C: V.118, L.119
Ligand excluded by PLIPEDO.16: 8 residues within 4Å:- Chain C: A.109, Y.110, S.111, S.112, M.143
- Chain D: Q.55, V.70, L.119
Ligand excluded by PLIPEDO.17: 7 residues within 4Å:- Chain C: P.38, G.39, P.40, Y.166
- Chain D: L.23, F.95, R.96
Ligand excluded by PLIPEDO.18: 5 residues within 4Å:- Chain C: P.45, L.46, T.47, W.77, K.78
Ligand excluded by PLIPEDO.19: 5 residues within 4Å:- Chain C: T.41, K.42, E.170
- Chain D: I.92, D.94
Ligand excluded by PLIPEDO.21: 6 residues within 4Å:- Chain C: T.108, A.109, S.112, R.114, V.116
- Chain D: L.119
Ligand excluded by PLIPEDO.25: 7 residues within 4Å:- Chain D: P.38, G.39, P.40, Y.166
- Chain E: L.23, F.95, R.96
Ligand excluded by PLIPEDO.26: 4 residues within 4Å:- Chain D: T.41, K.42
- Chain E: I.92, D.94
Ligand excluded by PLIPEDO.28: 7 residues within 4Å:- Chain D: A.109, S.112, R.114, P.115, V.116
- Chain E: L.119
- Ligands: PO4.24
Ligand excluded by PLIPEDO.29: 6 residues within 4Å:- Chain A: L.119
- Chain E: T.108, A.109, S.112, P.115, V.116
Ligand excluded by PLIPEDO.33: 8 residues within 4Å:- Chain A: L.23, F.95, R.96
- Chain E: P.38, G.39, P.40, Y.166, E.170
Ligand excluded by PLIPEDO.34: 5 residues within 4Å:- Chain E: L.46, T.47, R.76, W.77, K.78
Ligand excluded by PLIPEDO.35: 7 residues within 4Å:- Chain D: R.114
- Chain E: D.68, P.115, Q.117, R.139, L.140, S.141
Ligand excluded by PLIP- 5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.7: 2 residues within 4Å:- Chain A: N.91
- Chain E: D.43
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.91
NAG.12: 3 residues within 4Å:- Chain B: N.87, G.90, N.91
No protein-ligand interaction detected (PLIP)NAG.20: 3 residues within 4Å:- Chain C: N.87, G.90, N.91
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.87
NAG.27: 3 residues within 4Å:- Chain D: N.87, G.90, N.91
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:N.87, D:N.91
NAG.36: 3 residues within 4Å:- Chain E: N.87, G.90, N.91
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:N.87, E:N.91
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bueno, R.V. et al., Interactions between 2'-fluoro-(carbamoylpyridinyl)deschloroepibatidine analogues and acetylcholine-binding protein inform on potent antagonist activity against nicotinic receptors. Acta Crystallogr.,Sect.D (2022)
- Release Date
- 2020-03-18
- Peptides
- Soluble acetylcholine receptor: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
FB
GC
HD
IE
J
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-pentamer
- Ligands
- 5 x JC8: 6-[5-[(1~{R},2~{R},4~{S})-7-azabicyclo[2.2.1]heptan-2-yl]-2-fluoranyl-pyridin-3-yl]pyridine-3-carboxamide(Non-covalent)
- 8 x PO4: PHOSPHATE ION(Non-functional Binders)
- 18 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bueno, R.V. et al., Interactions between 2'-fluoro-(carbamoylpyridinyl)deschloroepibatidine analogues and acetylcholine-binding protein inform on potent antagonist activity against nicotinic receptors. Acta Crystallogr.,Sect.D (2022)
- Release Date
- 2020-03-18
- Peptides
- Soluble acetylcholine receptor: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
FB
GC
HD
IE
J